Brazilian butt lift ban for Miami doctor after a death. Where's he working now?
The Miami area surgeon in a 2023 Brazilian butt lift death has performed his last legal BBL surgery in Florida after the state's Board of Medicine approved his punishment.
Dr. Ernesto Torres will also pay $15,229 — a $10,000 fine and $5,229 in reimbursement of the Florida Department of Health's case costs. He also has to complete five hours of continuing medical education in laws, rules and ethics.
The next section of the settlement agreement says Torres' 'practice is permanently restricted to prohibit [Torres] from performing gluteal fat transfer/Brazilian Butt Lifts (BBLs).'
This is the first discipline for Torres since he became licensed in Florida on Aug. 31, 2012.
READ MORE: Unfit gas passer in Broward butt-lift death lost her license. Surgeon John Nees hasn't
The address on Torres' license is now that of Towers Medical Center, 1695 NW 110th Ave. Under 'Meet Our Surgeon,' the Towers website says Torres now handles 'hernias such as umbilical hernia, incisional hernia, epigastric hernia, and inguinal hernias minimally invasive. Other surgeries performed by Dr. Torres are gallbladder surgery, colon surgery, laparoscopic appendectomy, and much more.'
The surgery occurred at what was then Jireh Cosmetic Center Corp.'s Miami Lakes Plastic Surgery, 15450 New Barn Rd., suite 106. State records say Jireh Cosmetic Center still has a license at that location, but now is doing business as Serenity Lakes Surgery and Beauty. Torres is still listed as a physician.
Torres hasn't answered a phone message or an email from the Miami Herald about the surgery or the final order.
MORE: Violations by a Miami doctor led to a Brazilian butt lift death, state complaint says
The fatal Brazilian butt lift
According to the Florida Department of Health's administrative complaint, a 32-year-old patient went to Miami Lakes Plastic Surgery for a gluteal fat grafting, commonly called a 'Brazilian butt lift.' Fat is taken from the waist and back via liposuction and injected into the buttocks.
But the fat can't be injected into the actual glute muscles. That's against Florida administrative code because it can cause blood clots that block blood flow into the lungs, bilateral pulmonary embolism, which can be fatal.
The complaint said that's what happened here. Torres injected fat into the patient's glute muscles, her heart began beating rapidly, her blood pressure dropped and she suffered cardiac arrest. She died that night.
The autopsy named bilateral pulmonary fat emboli as the cause of death, with fat graft in several glute muscles and next to sciatic nerves.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Cat triggers rabies alert in Lake County
People who live in Lake County may want to keep their pets inside for a while. Officials with the Florida Department of Health in Lake County are tracking rabies cases among wild animals in the area. They said the issue started after a cat-related incident in the western part of Leesburg in Lake County. It's best for people and domestic animals to steer clear of physical contact with wild animals like raccoons, bats, foxes, skunks, otters, bobcats and coyotes. These animals pose a higher risk of exposure to humans and may require rabies post-exposure treatment. If you are exposed to rabies, receiving appropriate treatment after exposure will protect you from the risk of rabies. This rabies alert is for 60 days and includes the following boundaries in Lake County: · Northern boundary: Alabama Avenue · Southern boundary: North 14th St. · Eastern boundary: Edgewood Avenue · Western boundary: Oklahoma Avenue Take the following precautions to prevent rabies exposure: · Immunize your pets and livestock based on your veterinarian's recommended schedule. · Keep pets under direct supervision and on a leash, and keep livestock secured on your property. If an animal bites your pet or livestock, seek veterinary assistance for the animal immediately and contact Lake County Animal Control at 352-343-9500. · Avoid contact with wild or stray animals. Do not handle, feed, or unintentionally attract them with outdoor pet food, open garbage cans, or other food sources. If you have been bitten or scratched by a wild or domestic animal, seek medical attention, and report the injury to DOH-Lake by calling 352-221-2609 or after hours at 352-250-7329. · Never adopt wild animals or bring them into your home; instead, contact a licensed wildlife rehabilitator. · Call your local animal control agency to remove stray animals from your neighborhood. Contact Lake County Animal Control at 352-343-9500 · Prevent wildlife, including bats, from entering living quarters or occupied spaces in homes, schools, and other areas where they might contact people and pets. For more information on rabies, please visit this site. Or contact DOH-Lake at 352-771-5500. Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live.
Yahoo
3 days ago
- Yahoo
DOH-Bay reminds residents of Revive Awareness Day
BAY COUNTY, Fla. (WMBB) – The Florida Department of Health in Bay County observes Revive Awareness Day on Friday, June 6. According to a news release, the DOH-Bay wants to remind residents that naloxone (Narcan) is a medication that can reverse the effects of an opioid overdose. Floridians can find Narcan for their community by calling DOH-Bay at 850-872-4455. The DOH-Bay offers Narcan at the Florida Department of Health in Bay County, 597 W 11 St., Panama City, FL, 32401. DOH-Bay offers the following information: All Floridians need to know the signs of an overdose, which include: -Small, constricted 'pinpoint pupils'-Falling asleep or losing consciousness-Slow, weak, or not breathing-Choking or gurgling sounds-Cold or clammy skin-Discolored skin, especially lips and nails-Limp body What to Do if You Think Someone is Overdosing: -If you suspect someone has overdosed, call 911 immediately.-Administer Narcan if available, lay the person on their side to prevent choking, andtry to keep them awake and breathing until emergency assistance arrives. The HEROS Program:-The Florida Department of Health's Helping Emergency Responders Obtain Support(HEROS) program provides naloxone to emergency response agencies throughout the Florida agency that employs licensed emergency responders may apply to the HEROSprogram. If You or a Loved One Needs Help:The Coordinated Opioid Recovery (CORE) Network is the first of its kind in the U.S. and aimsto eliminate the stigma of addiction and treat substance use disorder as a disease, with the same level of continuous care. Floridians battling with addiction can utilize the CORE Network for stabilization and to receive medication-assisted treatment from a network of specialized medical experts that will help guide them on a sustained pathway to healthy success. Spearheaded by First Lady Casey DeSantis, 'The Facts. Your Future.' campaign focuses onsupporting students statewide to ensure they receive prevention instruction and encouragementto protect and maintain their health, avoid substance misuse, and discourage risky behaviors sothey can thrive and flourish for life. This campaign is an interactive approach to ensure students are informed and can make safe decisions as they grow. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
4 days ago
- Yahoo
MGI Tech Expands Partnership with Fiocruz to Accelerate Advances in Epidemiological Surveillance and Personalized Medicine in Brazil
Next-generation technologies will help increase the agility and efficiency of genetic sequencing to tackle several diseases SAO PAULO, June 5, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, has just expanded its partnership with the Diagnostic Support Unit (UNADIG), a non-profit laboratory of the Oswaldo Cruz Foundation (FIOCRUZ), one of Brazil's leading scientific institutions, to support public health in the country. MGI's first scientific collaboration with UNADIG was established during the COVID-19 pandemic. With the MGISP-960 extractor equipment from MGI, UNADIG was able to process more than 3 million samples from across the country during this period. With the end of the pandemic, UNADIG expanded its portfolio and included different methodological platforms in its laboratory facilities (chemiluminescence, Elisa, photometry, immunoturbidimetry, and indirect potentiometry), as well as genetic sequencing. The new agreement between UNADIG and MGI will enable maintain the molecular tests (RT-PCR) but advances in DNA-based testing. UNADIG has two large high-processing laboratories. The the Clinical Diagnostic Laboratory (DCLIN) has a daily processing capacity of around 29,000 samples, and the Molecular Diagnostic Laboratory (DIMOL) can process between 9,000 and 15,000 RT-PCR samples. In 2025, with the sequencing support of MGI, a process in molecular genetics will begin with the capacity to process over 2,000 samples weekly for the diagnosis of infectious, genetic, and main types of cancer (breast, ovarian, colorectal and prostate), in addition of individual gene sequencing for sporadic or hereditary cancers. "The goal of this collaboration is to help transform healthcare delivery, with a focus on efficiency and accessibility, as it will contribute to expanding access for the Brazilian population to high-complexity laboratory tests with greater speed and reduced costs. This will accelerate the diagnosis and treatment of oncological and epidemiological diseases, strengthening the country's response to outbreaks and epidemics", Carlos Carpio, Senior Commercial Director of MGI Latin America and General Manager for Brazil, explains. To expand its operational and analytical capacity for sample and test processing, UNADIG has acquired state-of-the-art equipment from MGI, including 14 units MGISP-960 nucleic acid extractor; 1 unit MGISP-100 automated genomic library preparation system; 2 units DNBSEQ-G400 and 1 unit DNBSEQ-T7 sequencers; and 1 unit ZTRON platform for genomic data storage and analysis. These technologies also ensure greater speed and accuracy in processing, while enhancing sample handling safety and reducing the risk of contamination. "Precision medicine brings significant benefits to patients and to the public health system, enabling early diagnoses, more effective treatments and the optimization of clinical protocols. This results in cost savings, waste reduction and greater effectiveness of tests and therapies. MGI's equipment, which allows automated processes, helps us achieve these goals", Erika Martins de Carvalho, General Coordinator of UNADIG-RJ of the Vice Presidency of Health Production and Innovation at Fiocruz, says. Increasing the presence in Brazil With the goal of making genetic sequencing more accessible, efficient and scalable through comprehensive solutions, MGI has been expanding its operations in Brazil. In 2024, the company inaugurated a Customer Experience Center in São Paulo, created to offer clinical laboratories and healthcare institutions a dedicated space for hands-on demonstrations. The center aims to enhance technical training and familiarity with MGI's technologies. Highly qualified professionals lead certified training sessions, presentations, evaluations and provide local support for new applications. Also in 2024, MGI established partnerships with Dasa, Grupo Sabin and Oncoclínicas&Co to expand the use of genetic sequencing in Brazil through the adoption of advanced technologies for genetic testing aimed at diagnosing cancers, rare diseases and other conditions, strengthening personalized medicine in the country. About MGI MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI), is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and have established research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. To learn more, please visit , Linkedin, X, and Youtube. View original content to download multimedia: SOURCE MGI TECH Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
